Supports collaborative teams focused on generating, validating, and distributing high-quality preclinical tools like antibodies, viral vectors, and mouse models for at least 5 Parkinson's disease targets prioritized by ASAP. Emphasizes tool-specific projects with strong open science policies and multi-institutional collaboration to accelerate therapeutic research and development. Hypothesis-driven research is excluded.
Eligible applicants are collaborative teams with a Coordinating Lead PI holding an academic or senior private sector appointment, a Core/Repository Co-Investigator from a commercial or academic core, 2-5 PIs with relevant doctoral degrees, representing at least two disciplines and institutions. Core
